Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Munting A, Cavassini M, Braun D, Günthard HF, Kusejko K, Surial B, Furrer H, Rauch A, Ustero P, Calmy A, Stoeckle M, Battegay M, Marzolini C, Andre P, Guidi M, Buclin T, Decosterd LA, On Behalf Of The Swiss Hiv Cohort Study.
Thoueille P, et al. Among authors: andre p.
Pharmaceutics. 2022 Jul 29;14(8):1588. doi: 10.3390/pharmaceutics14081588.
Pharmaceutics. 2022.
PMID: 36015214
Free PMC article.